Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Debt & Borrowing

Samrat Pharmachem Debt & Borrowing

Samrat Pharmachem Limited filed its initial disclosure under the SEBI Large Corporate framework for the financial year. The company confirmed it does not meet the criteria to be identified as a Large Corporate, reporting zero outstanding borrowings as of March 31.

Source

BSE filing, NSE: SAMRATPH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Samrat Pharmachem Ltd: key numbers

Share price
₹271.35
Market cap
₹83.84 Cr
Revenue (annual)
₹289.7 Cr
Net profit (annual)
₹-3.31 Cr
P/E (TTM)
-38.0×Sector 48.7×
Promoter holding
49.09%+0.00% QoQ
FII holding
3.24%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Samrat Pharmachem Ltd

All →

Other debt & borrowing announcements

All →